University of London: Current Standards of Drug Regulation are Insufficient and Should Be Improved for Better Outcomes
September 17, 2021
September 17, 2021
LONDON, England, Sept. 17 (TNSRes) -- The University of London - London School of Economics and Political Science issued the following news release:
A growing number of drugs are being approved on the basis of "surrogate endpoints". These are indirect measures that are intended to be used as a substitute for a clinically meaningful endpoint. New research co-led by Dr Huseyin Naci of LSE Health and published in the British Medical Journal (BMJ) raises this as a concern argu . . .
A growing number of drugs are being approved on the basis of "surrogate endpoints". These are indirect measures that are intended to be used as a substitute for a clinically meaningful endpoint. New research co-led by Dr Huseyin Naci of LSE Health and published in the British Medical Journal (BMJ) raises this as a concern argu . . .